Skip Navigation

JNCI Journal of the National Cancer Institute 2001 93(18):1420-1421; doi:10.1093/jnci/93.18.1420-a
© 2001 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Mirchandani, D.
Right arrow Articles by Muggia, F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Mirchandani, D.
Right arrow Articles by Muggia, F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 93, No. 18, 1420-1421, September 19, 2001
© 2001 Oxford University Press

CORRESPONDENCE

Re: Prognosis and Treatment of Patients With Breast Tumors of One Centimeter or Less and Negative Axillary Lymph Nodes

Deepu Mirchandani, Franco Muggia

Affiliation of authors: Kaplan Comprehensive Cancer Center, New York University School of Medicine, NY.

Correspondence to: Deepu Mirchandani, M.D., Kaplan Comprehensive Cancer Center, New York University, 462 First Ave., Bldg. C + D, Rm. 556, New York, NY 10016. (e-mail: mirdeep@aol.com).

Fisher et al. (1) recommend adjuvant chemohormonal therapy for all patients with small breast cancers. The editorial by Lippman and Hayes (2) emphasizes the need for definitive clinical trials before routine acceptance of adjuvant chemotherapy. Our letter extends the discussion on risks and benefits to adjuvant hormonal treatment, in relation to age and . . . [Full Text of this Article]

REFERENCES


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?